Monday Dec 7 | Washington Business Journal
MiddleBrook Pharmaceuticals cuts staff
MiddleBrook Pharmaceuticals Inc. made its second round of layoffs in four months to cut costs, this time shrinking its work force down by nearly a third and affecting at least one Germantown-based executive, the Washington Business Journal reported.
MiddleBrook Pharmaceuticals Reduces Field Sales Force and Corporate...
Dec 3, 2009 - MiddleBrook Pharmaceuticals, Inc. today announced a reduction of its field sales force and corporate staff.
Public relations, press release distribution, investor relations, SEC filing
JACKSONVILLE, Fla.-- --Regency Centers Corporation announced today that it plans to commence an offering of 8,000,000 shares of its common stock in an... WESTLAKE, Texas-- --MiddleBrook Pharmaceuticals, Inc.
Ex-Biotech CEO, Entrepreneur Form VC Firm To Create Drug Companies
Last year Ed Rudnic strolled onto a golf course as a seasoned, but unemployed, biotech CEO, ready for a respite after new investors brought in their own team to manage the company he founded, Germantown-based MiddleBrook Pharmaceuticals Inc.
New venture capital firm aims to boost biotech
Last year Ed Rudnic strolled onto a golf course as a seasoned, but unemployed, biotech CEO, ready for a respite after new investors brought in their own team to manage the company he founded, Germantown-based MiddleBrook Pharmaceuticals Inc.
Customer Interaction Solutions
MiddleBrook Pharmaceuticals Down 6.7% Since SmarTrend's Sell Recommendation
SmarTrend, our proprietary pattern recognition system, called a Downtrend for MiddleBrook Pharmaceuticals on October 13, 2009 at $1.05. Since then, MiddleBrook Pharmaceuticals has returned 6.7% as of Friday's recent price of $0.98. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.
Public relations, press release distribution, investor relations, SEC filing
The Partnership intends to use the net proceeds from th... SALT LAKE CITY-- --Today, St.
MiddleBrook Pharmaceuticals Reports Second Quarter 2009 Results
MiddleBrook's second quarter 2009 revenue totaled $2.1 million. MiddleBrook launched MOXATAG.com , a website for healthcare professionals and patients.
MiddleBrook Pharmaceuticals Reports Second Quarter 2009 Results
MiddleBrook's second quarter 2009 revenue totaled $2.1 million. MiddleBrook launched MOXATAG.com , a website for healthcare professionals and patients.
MiddleBrook secures $10 million in credit
MiddleBrook Pharmaceuticals Inc. , a pharmaceutical company focused on commercializing a new treatment for strep throat, has obtained a two-year $10 million revolving line of credit.
Maryland claims MiddleBrook Pharmaceuticals owes it money
MiddleBrook Pharmaceuticals Inc. was slapped with a lien by Maryland for unpaid taxes that the company's current leaders say predated them and has since been paid in full.
A Rockville, MD-based contract services firm is taking 20,249 square feet of new space in a local high-bay flex building.
Also on Topix